This inventor holds 1 USPTO granted patent. Top assignee: Roche Molecular Systems, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Gabriele Zangenberg: Innovator in Genetic Research
Introduction
Gabriele Zangenberg is a notable inventor based in Tutzing, Germany. He has made significant contributions to the field of genetic research, particularly in understanding the genetic factors associated with various diseases.
Latest Patents
Zangenberg holds a patent for the "TCF-1 nucleotide sequence variation - Methods and reagents for determining sequence variants present at the TCF-1 locus." This invention facilitates the identification of individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, as well as Th2 diseases, including allergic asthma or atopy. He has 1 patent to his name.
Career Highlights
Gabriele Zangenberg is currently employed at Roche Molecular Systems, Inc., where he continues to advance research in molecular genetics. His work has implications for improving diagnostic methods and therapeutic strategies for various health conditions.
Collaborations
Zangenberg has collaborated with notable colleagues, including Andrew Grupe and Ann Begovich, who contribute to the research environment at Roche Molecular Systems, Inc. Their combined expertise enhances the innovative efforts within the company.
Conclusion
Gabriele Zangenberg's contributions to genetic research and his innovative patent highlight his role as a key figure in the scientific community. His work continues to pave the way for advancements in understanding genetic diseases.